. 2012 Dec 27;2:190. doi: 10.3389/fonc.2012.00190

Table 3.

Trends in Recommended screening among working cancer survivors (National health interview survey 1999–2010).

Survey year	Average annual sample size		Percent adherent to screening						Average annual% change	Regression
	Observed N	Population estimate	1999	2000	2003	2005	2008	2010		Slope ± SE^b	P^c
COLORECTAL SCREENING^a
White-collar	480	275,468	n/a	51.3	66.6	67.3	66.0	71.8	5.2	0.014 ± 0.003	< 0.001
Blue-collar	150	83,840	n/a	32.1	47.2	59.4	58.7	63.6	7.9	0.018 ± 0.021	0.004
Service	94	50,454	n/a	48.9	62.0	54.8	57.4	62.3	3.4	0.011 ± 0.006	0.075
MAMMOGRAM^a
White-collar	388	208,109	84.1	81.2	78.8	81.7	80.5	77.4	−1.3	−0.003 ± 0.002	0.230
Blue-collar	60	30,142	63.9	58.1	77.1	69.9	68.5	76.3	2.5	0.013 ± 0.006	0.024
Service	268	36,162	88.4	84.0	82.5	64.5	59.3	72.1	−3.3	−0.005 ± 0.006	0.461
CLINICAL BREAST EXAM^a
White-collar	419	188,170	88.5	83.0	n/a	75.2	n/a	64.8	−7.9	−0.117 ± 0.002	<0.001
Blue-collar	68	330,507	78.4	63.3	n/a	63.2	n/a	64.0	−4.8	−0.007 ± 0.005	0.201
Service	76	35,832	87.3	71.3	n/a	58.3	n/a	62.6	−8.2	−0.003 ± 0.006	0.662
PAP TEST^a
White-collar	415	221,681	91.7	93.6	89.6	88.8	88.0	79.3	−4.7	−0.007 ± 0.002	<0.001
Blue-collar	66	32,245	87.6	93.7	92.6	79.5	76.1	70.1	−4.6	−0.011 ± 0.004	0.01
Service	84	44,096	89.2	96.9	89.4	88.6	80.2	84.0	−2.0	−0.006 ± 0.004	0.18
PROSTATE SPECIFIC ANTIGEN TEST^a
White-collar	152	96,002	78.4	70.0	69.0	71.5	74.8	66.8	−2.3	−0.002 ± 0.004	0.613
Blue-collar	78	46,138	69.8	52.5	81.0	61.3	62.3	59.7	−2.0	−0.006 ± 0.008	0.437
Service	32	17,302	73.2	64.5	61.9	49.7	71.5	64.4	−1.8	0.009 ± 0.007	0.247

^aToo few observations in farming sector.

^bStandard error of the mean.

^cp-value.